STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT
Not Applicable
Not yet recruiting
- Conditions
- ST Elevation Myocardial Infarction
- Interventions
- Device: Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- IGLESIAS Juan Fernando
- Target Recruit Count
- 350
- Registration Number
- NCT05785897
- Locations
- 🇨ðŸ‡
Geneva University Hospitals, Geneva, Switzerland
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
Not Applicable
Not yet recruiting
- Conditions
- Left Main Coronary Artery Stenosis
- Interventions
- Device: LMCA PCI with Supraflex Cruz ultrathin-strut biodegradable polymer sirolimus-eluting stent (Sahajanand Medical Technologies Ltd., Surat, India).Drug: P2Y12 inhibitor-based SAPT after short DAPT
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- IGLESIAS Juan Fernando
- Target Recruit Count
- 828
- Registration Number
- NCT05650411
- Locations
- 🇨ðŸ‡
Zurich University Hospital, Zürich, Switzerland
DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention
Not Applicable
Recruiting
- Conditions
- Vascular Access Site Occlusion
- Interventions
- Procedure: Complex PCI with Ultimaster family drug-eluting stent (Terumo Corp., Japan)
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- IGLESIAS Juan Fernando
- Target Recruit Count
- 708
- Registration Number
- NCT05490238
- Locations
- 🇧🇪
CHU Saint-Pierre, Bruxelles, Belgium
🇧🇪CHU de Charleroi, Charleroi, Belgium
🇧🇪Hôpital de La Louvière - Site Jolimont, La Louvière, Belgium
© Copyright 2025. All Rights Reserved by MedPath